Sublingual immunotherapy (SLIT) is a safe and efficient treatment for type 1 allergies; however, the underlying immunological mechanisms, particularly the phenotype of oral antigen-presenting cells (APCs) responsible for the induction of regulatory T (Treg) cells, remain unclear. We show here that the sublingual application of ovalbumin (OVA) induced antigen-specific 
INTRODUCTION
Sublingual immunotherapy (SLIT) is an allergen-specific treatment for type 1 allergies, such as allergic rhinitis, with an improved safety profile and long-lasting effects.
1,2 SLIT operates by acting on the sublingual mucosa and increases allergen tolerance, possibly with the redirection of allergenspecific CD4 þ T-cell responses from T-helper (Th) 2 to Th1 and the generation of regulatory T (Treg) cells. [1] [2] [3] Treg cells are induced in the thymus and are also induced from naive CD4 þ T cells in the periphery, and the transcriptional factor Foxp3 is required for the development and maintenance of the immunosuppressive functions of Treg cells. 4 SLIT has been associated with increased numbers of Foxp3 þ cells in biopsies from the sublingual mucosa 5 and interleukin (IL)-10-producing Treg cells in peripheral blood samples. 6, 7 Thus, a deeper understanding of the mechanisms underlying Treg-cell induction by SLIT may contribute to the development of new therapeutic strategies.
The oral cavity is colonized by a large number of commensal microbes and is constantly exposed to food antigens. However, acute allergic and inflammatory reactions occur relatively rarely at the oral mucosa. 1 SLIT takes advantage of the protolerogenic property of the oral mucosa for its beneficial effects and good safety profile; however, the underlying immunological mechanisms currently remain unclear. The oral mucosa consists of two main layers, the stratified epithelium and underlying lamina propria (LP), which are the equivalents of the epidermis and dermis of the skin, respectively. 8 In the sublingual mucosa, four subsets of antigen-presenting cells (APCs) with distinct tissue distributions have been detected using immunohistochemistry and flow cytometry: (i) a major subpopulation of CD11b þ CD11c À and CD11b þ CD11c þ APCs in the LP, (ii) a minor subset of CD207 (langerin) þ Langerhans cells (LCs) located in the epithelium, and (iii) B220 þ 120G8 þ plasmacytoid dendritic cells (pDCs) found in the LP. 9 Among these APCs, LCs and CD11b þ CD11c À macrophage (Mf)-like cells are considered to be critical for capturing sublingual antigens. [9] [10] [11] A previous study suggested that oral CD11b þ CD11c À Mf-like cells presented sublingual antigens in draining lymph nodes (LNs) and promoted the differentiation of interferon-g-producing Th1 cells and Foxp3 þ Treg cells. 11 However, the role of oral CD11c þ classical dendritic cells (cDCs) in tolerance induction has not yet been examined. 8 In contrast, the mechanisms that underlie systemic tolerance to orally administered antigens, which is called ''oral tolerance'' and originates in the intestinal immune system, have been extensively investigated. 12 In the LP of the intestines, most major histocompatibility complex II (MHCII) þ CD11c þ dendritic cells (DCs) express CD103. 13, 14 These CD103 þ DCs are migratory cDCs in the LP. Intestinal CD103 þ cDCs produce the vitamin A metabolite retinoic acid (RA), and intestinal CD103
þ cDC-derived RA acts as a cofactor in the transforming growth factor (TGF)-b-mediated conversion of naive CD4
þ T cells into Foxp3 þ Treg cells. 15, 16 Intestinal CD103 þ cDCs express high levels of aldh1a2, the gene encoding retinal dehydrogenase (RALDH) 2, 15 which is a key enzyme in the metabolic conversion of retinal to RA. Another population in the intestinal LP was shown to be CX3CR1 high tissue-resident Mfs. 13 CD64, the high-affinity IgG receptor FcgRI, was recently identified as a specific marker for Mfs, including intestinal CX3CR1 high cells. 17, 18 We recently reported that sublingual antigens were transported across sublingual ductal epithelial cells to oral APCs around the duct in mice. 19 Therefore, we herein attempted to accurately identify and characterize oral APCs and clarify their roles in SLIT on the basis of established evidence regarding the properties of intestinal DCs. The results obtained revealed the previously unappreciated role of oral cDCs in Treg-cell induction and provide a rationale for developing cDC-based therapeutic approaches in SLIT.
RESULTS

Sublingual administration of soluble protein antigen induces antigen-specific Foxp3 þ Treg cells in draining ManLNs
It currently remains unclear whether SLIT, in effect, induces Foxp3 þ Treg cells in vivo. In order to examine this, ovalbumin (OVA)-specific naive OT-II CD4 þ T cells (CD45.2 þ ) were adoptively transferred into CD45.1 þ congenic mice, and the OVA protein was sublingually administered to the recipients on days 1 and 2. On day 5, the transferred OT-II T cells were detected in ManLNs, the draining LNs of the sublingual mucosa, 20 and in non-draining auricular and mesenteric LNs (MesLNs), whereas the marked conversion of Foxp3 þ cells was only detected in the draining ManLNs (Figure 1a) . after the sublingual application of OVA (Figure 1b, c) . Furthermore, the transferred OT-II CD4 þ T cells expressed interferon-g, but not IL-4, IL-10, or IL-17A (Figure 1d) . These results clearly indicated that in addition to Th1 cells, SLIT was capable of inducing antigen-specific Foxp3 þ Treg cells in draining ManLNs.
Classification of steady-state oral APCs by flow cytometry
Recent advances in defining mononuclear phagocytes led us to revisit the classification of oral APCs. 14, 21, 22 We isolated cells from the lingual and sublingual tissues by enzymatic digestion using trypsin-EDTA followed by collagenase, and analyzed them by flow cytometry. By combining the expression of CD64 and CD11c, oral APCs were separated into CD64 þ Mfs and MHCII þ CD64 À CD11c þ cells (Figure 2a) . The former consisted of MHCII þ and MHCII À cells, as recently described in the murine skin and heart. 23, 24 The latter was subdivided into CD207 þ and CD207 À cells. CD207 þ cells strongly expressed EpCAM (CD326) (Figure 2a) , as previously shown in epidermal LCs, 25 and were not recovered by the treatment with collagenase alone (Figure 2b ) because collagenase does not have the ability to digest the epithelium. These results suggested that, among
þ cells are oral LCs that reside in the epithelium, while CD207
À cells are oral cDCs in the LP. The absolute numbers showed that the predominant population comprised Mfs, followed by cDCs and then LCs in the tissues (Figure 2c ).
Flt3 ligand (Flt3L) has a key and non-redundant role in DC development, whereas Mfs and LCs develop independently of Flt3L. 14, 21, 22 Therefore, in order to identify Flt3L-dependent oral DCs, mice were injected with B16 melanoma cells constitutively secreting Flt3L (B16-Flt3L cells) (Supplementary Figure S1a online) , and when the tumor size reached 1-2 cm in diameter after 14-18 days, the number of APC subsets in the lingual and sublingual tissues were analyzed by flow cytometry. cDCs expanded more in B16-Flt3L-carrying mice than in control B16-carrying mice, irrespective of their expression of CD103 and CD11b (Supplementary Figure S1b , c, f). CD19 À B220 þ PDCA-1 þ pDCs, which were virtually absent in control mice, also significantly increased in B16-Flt3L-carrying mice; however, their total number was still low (Supplementary Figure S1d-f) . In contrast, Mfs, LCs, and CD19 þ B220 þ B cells did not expand in response to Flt3L. These results are consistent with our classification of oral APCs.
A recent study proposed that cDCs be subdivided into interferon regulatory factor (IRF) 8-dependent cDC1s and IRF4-dependent cDC2s, and also that CD172a (also known as signal regulatory protein a) may be used to identify cDC2s. 21 
Splenic CD8a
þ cDCs (prototypical cDC1s) and a small number of oral CD103 þ CD11b À cDCs expressed IRF8 and low levels of CD172a ( Figure 3) Figure S2a) . In the small intestinal (SI) LP, CD103 þ cDCs (both CD11b þ and CD11b À subsets) expressed definitive ALDH activity (Supplementary Figure  S2b) . In lingual and sublingual tissues, the expression of ALDH Figure S3) . We found that migratory CD103 À CD11b þ cDCs in ManLNs also displayed higher levels of ALDH activity than those of migratory LCs and CD103 þ DCs (Figure 6b , c), as observed in the lingual and sublingual tissues ( Figure 4) .
Among the three RA-producing isoenzymes, the mRNA expression of Aldh1a2, but not Aldh1a1 or Aldh1a3 was significantly higher in SI LP CD103 þ and oral CD103 À CD11b þ cDCs than in splenic cDCs ( Figure 7a ). Furthermore, migratory cDCs with these phenotypes also expressed Aldh1a2 mRNA in draining LNs, i.e., MesLNs and ManLNs ( Figure 7b ). As splenic cDCs only exhibited marginal ALDH activity (Supplementary Figure S2a) , these results indicated that RALDH2, which is encoded by Aldh1a2, was responsible for the RA-producing activity in SI LP CD103 þ cDCs, oral CD103 À CD11b þ cDCs, and their migratory counterparts in draining LNs.
Intestinal CD103 þ cDCs were previously reported to promote Foxp3 þ Treg-cell induction via the integrin avb8-mediated activation of latent TGF-b; 28, 29 therefore, the expression of integrin mRNAs was examined. In contrast to the broad expression of Itgav, Itgb8 was exclusively expressed in migratory CD103 þ cDCs in MesLNs, and migratory CD103 þ cDCs, CD103 À CD11b þ cDCs, and LCs in ManLNs ( Figure 7b ). The integrin avb6 is also known to activate latent TGF-b, and its expression was shown to be restricted to epithelial cells. 30 Consistent with this finding, Itgb6 was rarely detected in any of the populations examined in the present study (Figure 7a, b) . These results suggest that integrin avb8 on migratory APCs is responsible for the activation of TGF-b in draining LNs. Oral CD103 À CD11b þ cDCs transport sublingual antigen to draining ManLNs and induce antigen-specific Foxp3 þ Treg cells
We next attempted to identify the oral APC subsets that took up sublingually administered OVA in mice. After Alexa Fluor 488-labeled OVA was applied under the tongue, the labeled OVA was mainly taken up by CD64
þ Mfs in the lingual and sublingual tissues; uptake peaked after 1-8 h and decreased by 16 h (Figure 8a, b) . In ManLNs, fluorescent cells were detected 8-16 h after the sublingual application of OVA, and the majority of fluorescent cells were migratory CD103 À CD11b þ cDCs (Figure 8c, d) . These results suggested that the sublingual soluble protein antigen was transported to draining ManLNs by oral CD103 À CD11b þ cDCs in spite of its efficient uptake by oral Mfs in the mucosa.
We attempted to identify the APC subsets responsible for Foxp3 þ Treg-cell induction in ManLNs by SLIT. In order to achieve this, resident cDCs, migratory LCs, migratory CD103 þ cDCs, and migratory CD103 À CD11b þ cDCs were purified from ManLNs 16 h after the sublingual application of OVA in mice, and were then co-cultured with naive OT-II CD4 þ T cells ex vivo. Five days after being incubated, three migratory populations induced Foxp3 þ cells (Figure 9a) . Although the percentages of the induced Foxp3 þ Treg cells were similar among these migratory populations (Figure 9b) , their total number was significantly higher when stimulated with migratory CD103 À CD11b þ cDCs (Figure 9c ). In addition, the total number of migratory CD103 À CD11b þ cDCs was approximately threefold higher than that of migratory LCs or CD103 þ cDCs in ManLNs (Supplementary Figure S4) . These results suggested that migratory CD103 À CD11b þ cDCs in ManLNs were the main APCs responsible for the induction of antigen-specific Foxp3 þ Treg cells.
Suppression of hypersensitivity by SLIT-induced Treg cells
We determined whether SLIT-induced Treg cells are capable of suppressing hypersensitivity using the OVA-induced delayedtype hypersensitivity (DTH) model previously used to examine oral tolerance. 31 The sublingual administration of the OVA antigen prior to sensitization significantly suppressed the DTH response (Figure 10a ). CD25
þ Treg cells and CD25 À nonTreg cells were purified from the ManLNs of mice sublingually administered OVA (Supplementary Figure S5) , and then transferred to naive mice prior to sensitization with OVA. More than 95% of the Treg cells expressed Foxp3. Treg, but not non-Treg, cell transfer clearly suppressed the DTH response more than that in non-transferred mice (Figure 10b ).
In addition, CD25
þ Treg cells from vehicle control mice did not suppress this response. This result indicated that SLIT-induced antigen-specific Treg cells were responsible for tolerance to hypersensitivity. 
DISCUSSION
We herein demonstrated that the sublingual application of an antigen induced antigen-specific Foxp3 þ Treg cells in draining ManLNs, and that oral CD103 À CD11b þ cDCs were responsible for Treg-cell induction. The sublingual administration of OVA induced Foxp3 þ Treg cells in ManLNs, but not MesLNs, suggesting that although sublingual OVA may be swallowed, it was mostly absorbed into the sublingual mucosa and not, or to a much lesser extent, into the intestinal mucosa. ManLNs drain not only the oral mucosa, but also other head and neck regions, such as the nasolabial lymphatic plexus. 32 Therefore, the gating strategy of ManLNs may include cDCs from other head and neck regions as well as the sublingual region. This study also showed that SLIT was able to induce not only Treg cells, but also Th1 cells. These results suggest that oral commensal bacteria direct T-cell polarization toward Th1 cells as well as Treg cells in a steady state oral environment.
We found that RA-producing cDCs were characterized by the CD103 À CD11b þ phenotype in the oral mucosa, supporting the expression of CD103 not constituting a universal marker for RA-producing cDCs. 26 Previous findings 33 
subsets did not affect the numbers of Foxp3
þ Treg cells in the LP, and a reduction in Treg-cell numbers was only observed in animals lacking all CD103 þ cDCs, suggesting that these two CD103 þ cDC subsets contribute to the induction of tolerance. 34 to be extremely low in SI LP CD103 þ cDCs and oral CD103 À CD11b þ cDCs, whereas migratory CD103 þ cDCs in MesLNs and the three migratory subsets in ManLNs strongly expressed Itgb8. These results suggest that RA-producing and/or TGF-b-activating abilities in these APC subsets were upregulated upon migration to the draining LNs.
This study showed that the sublingual antigen was captured by oral Mfs, but not cDCs or LCs in the mucosa, after 1-8 h and detected in migratory CD103 À CD11b þ cDCs in ManLNs by 8-16 h. A previous study reported that, to induce oral tolerance, intestinal Mfs capture luminal OVA and transfer it to CD103 þ CD11b þ cDCs via a route involving gap junctions. 35 Therefore, oral Mfs may have transferred the sublingual antigen to oral CD103 À CD11b þ cDCs in the sublingual LP. Moreover, we recently reported, based on a histological analysis, that sublingual antigens, including OVA, were transported across sublingual ductal epithelial cells to oral APCs around the duct. 19 Thus, we assumed that sublingual soluble protein antigens may enter the sublingual LP via the sublingual ductal epithelium as well as sublingual mucosal epithelium in order to be captured by oral Mfs in the LP.
The implantation of B16 cells genetically engineered to secrete Flt3L results in the massive expansion of DCs in vivo. [36] [37] [38] As the injection of wild-type B16 cells into mice resulted in only minimal changes in peripheral blood counts and the splenocyte population, 37 this protocol is commonly used to expand DCs in vivo, e.g., the small intestine. 39, 40 In the present study, B16-carrying mice did not have an altered population of oral cDCs, LCs, and Mfs from that in wild-type mice (data not shown), and we consider oral cDCs and pDCs to have expanded in response to Flt3L in B16-Flt3L-carrying mice. A recent study strongly suggested that oral mucosal CD207 þ cells in the stratified epithelium are genuine LCs. 27 Furthermore, despite CD207 þ cDCs being present in the dermis of the skin, 25 the oral and vaginal mucosae appear to have no or very few CD207 þ cDCs in the LP, 27, 41 indicating that the oral CD207 þ cells detected in this study are LCs, not cDCs. This study showed that oral LCs did not expand in B16-Flt3L-carrying mice, whereas a recent study reported a reduction in oral LCs in Flt3-deficient mice. 27 This discrepancy may be explained by the limited space of the oral mucosal epithelium for the expansion of oral LCs in response to Flt3L.
In addition to the induction of Treg cells with TGF-b, RA also enhanced the expression of the integrin a4b7 and the chemokine receptor CCR9 on T cells upon activation and imprinted them with gut tropism. 42 Furthermore, this study showed that SLIT-induced Treg cells were able to suppress the DTH response as reported in oral tolerance. 31 Therefore, RA produced by cDCs in ManLNs may induce gut-homing receptors on antigen-specific Treg cells, and these Treg cells may, in turn, prevent hypersensitivity with the assistance of the intestinal immune system.
In conclusion, we herein revealed that oral CD103 À CD11b þ cDCs possessed the necessary properties to induce Foxp3 þ Treg cells, possibly in order to establish peripheral tolerance, i.e., SLIT. Many different subsets of cDCs in rodents and humans can be divided broadly on the basis of their requirement for transcription factors into cDC1 and cDC2, 21 and our phenotypic characterization suggested that oral CD103 À CD11b þ cDCs were classified into cDC2s. The gene expression profiles and functions of human CD1c þ cDCs resemble those of mouse cDC2s, 21, 43 suggesting that human oral CD1c þ cDCs may be the functional homologue of mouse oral CD103
À CD11b þ cDCs. Human CD1c þ cDCs have been commonly detected in biopsies from the sublingual mucosa. 5 Therefore, targeting oral CD1c þ cDCs may serve the development of new therapeutic strategies in SLIT.
METHODS
Mice. C57BL/6 (CD45.2 þ ) mice were purchased from Japan SLC (Hamamatsu, Japan). Congenic C57BL/6 CD45.1 þ mice were provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan. OT-II mice have been described previously 44 and were maintained on a C57BL/6 background (CD45.2 þ ). All experimental protocols were approved by the Institutional Animal Care and Use Committee and by the Genetic Modification Safety Committee of Tohoku University (Sendai, Japan).
Sublingual administration. OVA (25 mg ml À 1 ; Sigma-Aldrich, St Louis, MO) or Alexa Fluor 488-conjugated OVA (2.5 mg ml À 1 ; Life Technologies, Carlsbad, CA) was applied under the tongues of mice in 20-ml aliquots of phosphate-buffered saline (PBS) containing 3% carboxymethyl cellulose under ketamine-xylazine (50/20 mg kg À 1 , intraperitoneally) anesthesia, as described previously. 19 APC isolation. Mice were killed and then perfused with 20 ml of PBS through the left ventricle. The sublingual mucosae with tongues were excised by trimming off the roots of the tongues and cut into fragments. The tissues were incubated with 0.25% trypsin and 1 mM EDTA (trypsin-EDTA; Wako Pure Chemical, Osaka, Japan) for 1 h at 37 1C with shaking; this treatment was omitted in some experiments. After being washed with RPMI 1640 containing 10% fetal bovine serum, the tissues were further incubated with 1 mg ml À 1 of collagenase (Wako Pure Chemical) and 0.1 mg ml À 1 of DNase I (Sigma-Aldrich) in RPMI 1640 medium containing 10% fetal bovine serum, again for 1 h at 37 1C with shaking. Cells were then filtered, using a 70-mm cell strainer. SI LP cells were prepared, as described previously. 45 Lingual and sublingual mucosal and SI LP cells were further purified by density gradient centrifugation with Lympholyte-M (Cedarlane, Hornby, BC, Canada), except when absolute APC numbers were determined by flow cytometry. Regarding spleen and LN cells, the spleens and LNs were cut into pieces and incubated with 1 mg ml À 1 of collagenase D (Roche, Basel, Switzerland) and 0.1 mg ml À 1 of DNase I in RPMI 1640 medium containing 10% fetal bovine serum for 30 min at 37 1C with shaking. Spleen cells were depleted of red blood cells by hypotonic lysis. In the in vitro and ex vivo Treg-cell conversion assays and quantitative RT-PCR analysis, APCs were sorted on a FACSAria II cell sorter (BD Biosciences, San Jose, CA).
Flow cytometry. Cells were isolated, as described in the previous sections. Non-specific staining was blocked with anti-CD16/32 (2.4G2; produced in-house). Antibodies used for cell staining are listed in Supplementary Table S1 . Intracellular staining for Foxp3 and IRF8 was performed using a Foxp3 staining buffer set (eBioscience, San Diego, CA). Intracellular cytokines were stained as described previously. 46 Dead cells were stained with either DAPI or Zombie Yellow (BioLegend, San Diego, CA) and excluded. Absolute cell numbers were calculated using CountBright absolute counting beads (Life Technologies). Data were acquired on an LSRFortessa cell analyzer (BD Biosciences), and analyzed using FlowJo software (Tree Star, Ashland, OR).
In vivo Treg-cell conversion assay. Naive CD4 þ T cells (defined as CD4 þ NK-1.1 À CD62L high CD44 low CD25 À ) were purified from the spleens and LNs of OT-II mice (CD45.2 þ ) using CD4 þ T cell isolation kit II (Miltenyi Biotec, Bergish Gladbach, Germany), followed by a FACSAria II cell sorter. Purified cells (2 Â 10 6 ) were injected intravenously into CD45.1 þ mice. On days 1 and 2, OVA was applied under the tongue, as described in the section on sublingual administration. On day 5, LNs were harvested, and the expression of Foxp3 and intracellular cytokines by OT-II T cells was determined by flow cytometry. ALDEFLUOR assay. The ALDH activity of cells was determined using the ALDEFLUOR kit (STEMCELL Technologies, Vancouver, BC, Canada) according to the manufacturer's instructions. Briefly, cells (5 Â 10 6 cells per ml) were incubated in the dark for 30 min at 37 1C in ALDEFLUOR assay buffer containing ALDEFLUOR substrate, with or without the ALDH inhibitor diethylaminobenzaldehyde. Cells were subsequently stained with antibodies and DAPI, and analyzed by flow cytometry.
In vitro and ex vivo Treg-cell conversion assay. Regarding carboxyfluorescein succinimidyl ester (CFSE) labeling, naive OT-II CD4 þ T cells were treated in PBS containing 5 mM CFSE for 10 min at 37 1C. Cells were cultured in 200 ml of RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 50 mM 2-mercaptoethanol, and antibiotics. In the in vitro assay, 5 Â 10 3 APCs were co-cultured with 5 Â 10 4 CFSElabeled naive OT-II CD4 þ T cells in the presence of 100 nM OVA 323-339 peptide (MBL, Nagoya, Japan), with or without LE540 (Wako Pure Chemical) and LE135 (Cayman Chemical, Ann Arbor, MI) (1 mM each), 10 mg ml À 1 of anti-TGF-b (1D11; R&D systems), or control mouse IgG1 (MOPC-21; BioLegend). In the ex vivo assay, 2 Â 10 4 APCs that were isolated from the ManLNs of mice 16 h after the sublingual administration of OVA were co-cultured with 2 Â 10 5 CFSE-labeled naive OT-II CD4 þ T cells. Mouse recombinant IL-2 (BioLegend) was added to culture wells at 5 ng ml À 1 on days 2 and 4. On day 5, the dilution of CFSE and acquisition of Foxp3 by OT-II T cells were assessed by flow cytometry.
Quantitative RT-PCR. Isolated APCs (44 Â 10 4 ) were lysed in Isogen II (Nippon Gene, Tokyo, Japan), and total RNA was extracted, as described in the manufacturer's instructions. cDNA was generated using the Transcriptor First Strand cDNA Synthesis Kit (Roche). Quantitative RT-PCR was performed using LightCycler Fast Start DNA Master SYBR Green I and the LightCycler 1.5 system (Roche). The primers used for quantitative RT-PCR are shown in Supplementary Table S2 . Gene expression was normalized to Gapdh mRNA levels and expressed as relative units.
OVA-DTH. In order to sensitize mice to OVA, 150 mg OVA in a 100-ml emulsion of equal volumes of PBS and complete Freund's adjuvant (Difco Laboratories, Detroit, MI) was injected subcutaneously into each dorsal flank of mice. Two weeks later, their ear pinnae were challenged intradermally with 50 mg OVA in 20 ml PBS. Ear swelling was measured as described previously. SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
